{
  "DOI": "10.1186/s40246-017-0102-x",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-017-0102-x",
  "alternative-id": [
    "102"
  ],
  "article-number": "6",
  "author": [
    {
      "affiliation": [],
      "family": "Hirvonen",
      "given": "Elina A. M.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Pitkänen",
      "given": "Esa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hemminki",
      "given": "Kari",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Aaltonen",
      "given": "Lauri A.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kilpivaara",
      "given": "Outi",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2017,
        4,
        20
      ]
    ],
    "date-time": "2017-04-20T04:11:28Z",
    "timestamp": 1492661488000
  },
  "deposited": {
    "date-parts": [
      [
        2020,
        10,
        5
      ]
    ],
    "date-time": "2020-10-05T22:24:31Z",
    "timestamp": 1601936671000
  },
  "funder": [
    {
      "DOI": "10.13039/501100002341",
      "award": [
        "250345"
      ],
      "doi-asserted-by": "publisher",
      "name": "Suomen Akatemia"
    },
    {
      "DOI": "10.13039/501100006383",
      "award": [
        "137680"
      ],
      "doi-asserted-by": "publisher",
      "name": "Syöpäjärjestöt"
    },
    {
      "DOI": "10.13039/501100006306",
      "award": [
        "274474"
      ],
      "doi-asserted-by": "publisher",
      "name": "Sigrid Juséliuksen Säätiö"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        2,
        4
      ]
    ],
    "date-time": "2023-02-04T10:27:07Z",
    "timestamp": 1675506427051
  },
  "is-referenced-by-count": 11,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2017,
        4,
        20
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2017,
          12
        ]
      ]
    }
  },
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-017-0102-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2017,
        4,
        20
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2017,
        4,
        20
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2017,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1056/NEJM197610212951702",
      "author": "JW Adamson",
      "doi-asserted-by": "publisher",
      "first-page": "913",
      "journal-title": "N Engl J Med",
      "key": "102_CR1",
      "unstructured": "Adamson JW, Fialkow PJ, Murphy S, Prchal JF, Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. N Engl J Med. 1976;295:913–6.",
      "volume": "295",
      "year": "1976"
    },
    {
      "DOI": "10.1073/pnas.0601462103",
      "author": "CH Jamieson",
      "doi-asserted-by": "publisher",
      "first-page": "6224",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "102_CR2",
      "unstructured": "Jamieson CH, Gotlib J, Durocher JA, Chao MP, Mariappan MR, Lay M, et al. The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A. 2006;103:6224–9.",
      "volume": "103",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2015.61.6474",
      "author": "BL Stein",
      "doi-asserted-by": "publisher",
      "first-page": "3953",
      "journal-title": "J Clin Oncol",
      "key": "102_CR3",
      "unstructured": "Stein BL, Oh ST, Berenzon D, Hobbs GS, Kremyanskaya M, Rampal RK, et al. Polycythemia vera: an appraisal of the biology and management 10 years after the discovery of JAK2 V617F. J Clin Oncol. 2015;33:3953–60.",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1002/ajh.23690",
      "author": "GJ Titmarsh",
      "doi-asserted-by": "publisher",
      "first-page": "581",
      "journal-title": "Am J Hematol",
      "key": "102_CR4",
      "unstructured": "Titmarsh GJ, Duncombe AS, Mcmullin MF, O'rorke M, Mesa R, De Vocht F, et al. How common are myeloproliferative neoplasms? A systematic review and meta-analysis. Am J Hematol. 2014;89:581–7.",
      "volume": "89",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S0140-6736(05)74230-6",
      "author": "EJ Baxter",
      "doi-asserted-by": "publisher",
      "first-page": "1054",
      "journal-title": "Lancet",
      "key": "102_CR5",
      "unstructured": "Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054–61.",
      "volume": "365",
      "year": "2005"
    },
    {
      "DOI": "10.1038/nature03546",
      "author": "C James",
      "doi-asserted-by": "publisher",
      "first-page": "1144",
      "journal-title": "Nature",
      "key": "102_CR6",
      "unstructured": "James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434:1144–8.",
      "volume": "434",
      "year": "2005"
    },
    {
      "DOI": "10.1056/NEJMoa051113",
      "author": "R Kralovics",
      "doi-asserted-by": "publisher",
      "first-page": "1779",
      "journal-title": "N Engl J Med",
      "key": "102_CR7",
      "unstructured": "Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352:1779–90.",
      "volume": "352",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.ccr.2005.03.023",
      "author": "RL Levine",
      "doi-asserted-by": "publisher",
      "first-page": "387",
      "journal-title": "Cancer Cell",
      "key": "102_CR8",
      "unstructured": "Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7:387–97.",
      "volume": "7",
      "year": "2005"
    },
    {
      "DOI": "10.1182/blood-2007-04-083501",
      "author": "A Tefferi",
      "doi-asserted-by": "publisher",
      "first-page": "1092",
      "journal-title": "Blood",
      "key": "102_CR9",
      "unstructured": "Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007;110:1092–7.",
      "volume": "110",
      "year": "2007"
    },
    {
      "DOI": "10.1002/cncr.24440",
      "author": "A Tefferi",
      "doi-asserted-by": "publisher",
      "first-page": "3842",
      "journal-title": "Cancer",
      "key": "102_CR10",
      "unstructured": "Tefferi A, Thiele J, Vardiman JW. The 2008 World Health Organization classification system for myeloproliferative neoplasms: order out of chaos. Cancer. 2009;115:3842–7.",
      "volume": "115",
      "year": "2009"
    },
    {
      "DOI": "10.3109/10428194.2012.759656",
      "author": "BL Stein",
      "doi-asserted-by": "publisher",
      "first-page": "1989",
      "journal-title": "Leuk Lymphoma",
      "key": "102_CR11",
      "unstructured": "Stein BL, Saraf S, Sobol U, Halpern A, Shammo J, Rondelli D, et al. Age-related differences in disease characteristics and clinical outcomes in polycythemia vera. Leuk Lymphoma. 2013;54:1989–95.",
      "volume": "54",
      "year": "2013"
    },
    {
      "DOI": "10.1002/stem.1711",
      "author": "H Akada",
      "doi-asserted-by": "publisher",
      "first-page": "1878",
      "journal-title": "Stem Cells",
      "key": "102_CR12",
      "unstructured": "Akada H, Akada S, Hutchison RE, Sakamoto K, Wagner KU, Mohi G. Critical role of Jak2 in the maintenance and function of adult hematopoietic stem cells. Stem Cells. 2014;32:1878–89.",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.1016/0092-8674(93)90414-L",
      "author": "BA Witthuhn",
      "doi-asserted-by": "publisher",
      "first-page": "227",
      "journal-title": "Cell",
      "key": "102_CR13",
      "unstructured": "Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 1993;74:227–36.",
      "volume": "74",
      "year": "1993"
    },
    {
      "DOI": "10.1056/NEJMoa065202",
      "author": "LM Scott",
      "doi-asserted-by": "publisher",
      "first-page": "459",
      "journal-title": "N Engl J Med",
      "key": "102_CR14",
      "unstructured": "Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR, et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med. 2007;356:459–68.",
      "volume": "356",
      "year": "2007"
    },
    {
      "DOI": "10.1182/blood-2016-04-711283",
      "author": "L Lanikova",
      "doi-asserted-by": "publisher",
      "journal-title": "Blood",
      "key": "102_CR15",
      "unstructured": "Lanikova L, Babosova O, Swierczek S, Wang L, Wheeler DA, Divoky V, et al. Coexistence of gain-of-function JAK2 germline mutations with JAK2V617F in polycythemia vera. Blood. 2016. doi: 10.1182/blood-2016-04-711283 .",
      "year": "2016"
    },
    {
      "DOI": "10.1038/sj.leu.2402177",
      "author": "K Hemminki",
      "doi-asserted-by": "publisher",
      "first-page": "1313",
      "journal-title": "Leukemia",
      "key": "102_CR16",
      "unstructured": "Hemminki K, Jiang Y. Familial polycythemia vera: results from the Swedish Family-Cancer Database. Leukemia. 2001;15:1313–5.",
      "volume": "15",
      "year": "2001"
    },
    {
      "DOI": "10.1182/blood-2003-03-0885",
      "author": "R Kralovics",
      "doi-asserted-by": "publisher",
      "first-page": "3793",
      "journal-title": "Blood",
      "key": "102_CR17",
      "unstructured": "Kralovics R, Stockton DW, Prchal JT. Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease. Blood. 2003;102:3793–6.",
      "volume": "102",
      "year": "2003"
    },
    {
      "DOI": "10.1111/j.1365-2141.2005.05683.x",
      "author": "H Cario",
      "doi-asserted-by": "publisher",
      "first-page": "800",
      "journal-title": "Br J Haematol",
      "key": "102_CR18",
      "unstructured": "Cario H, Goerttler PS, Steimle C, Levine RL, Pahl HL. The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera. Br J Haematol. 2005;130:800–1.",
      "volume": "130",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ng.334",
      "author": "AV Jones",
      "doi-asserted-by": "publisher",
      "first-page": "446",
      "journal-title": "Nat Genet",
      "key": "102_CR19",
      "unstructured": "Jones AV, Chase A, Silver RT, Oscier D, Zoi K, Wang YL, et al. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet. 2009;41:446–9.",
      "volume": "41",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ng.342",
      "author": "O Kilpivaara",
      "doi-asserted-by": "publisher",
      "first-page": "455",
      "journal-title": "Nat Genet",
      "key": "102_CR20",
      "unstructured": "Kilpivaara O, Mukherjee S, Schram AM, Wadleigh M, Mullally A, Ebert BL, et al. A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet. 2009;41:455–9.",
      "volume": "41",
      "year": "2009"
    },
    {
      "DOI": "10.1038/ng.341",
      "author": "D Olcaydu",
      "doi-asserted-by": "publisher",
      "first-page": "450",
      "journal-title": "Nat Genet",
      "key": "102_CR21",
      "unstructured": "Olcaydu D, Harutyunyan A, Jager R, Berg T, Gisslinger B, Pabinger I, et al. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet. 2009;41:450–4.",
      "volume": "41",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s00277-010-0960-y",
      "author": "AP Trifa",
      "doi-asserted-by": "publisher",
      "first-page": "979",
      "journal-title": "Ann Hematol",
      "key": "102_CR22",
      "unstructured": "Trifa AP, Cucuianu A, Petrov L, Urian L, Militaru MS, Dima D, et al. The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms. Ann Hematol. 2010;89:979–83.",
      "volume": "89",
      "year": "2010"
    },
    {
      "DOI": "10.1038/leu.2014.48",
      "author": "A Oddsson",
      "doi-asserted-by": "publisher",
      "first-page": "1371",
      "journal-title": "Leukemia",
      "key": "102_CR23",
      "unstructured": "Oddsson A, Kristinsson SY, Helgason H, Gudbjartsson DF, Masson G, Sigurdsson A, et al. The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms. Leukemia. 2014;28:1371–4.",
      "volume": "28",
      "year": "2014"
    },
    {
      "DOI": "10.1038/ng.3380",
      "author": "J Saliba",
      "doi-asserted-by": "publisher",
      "first-page": "1131",
      "journal-title": "Nat Genet",
      "key": "102_CR24",
      "unstructured": "Saliba J, Saint-Martin C, Di Stefano A, Lenglet G, Marty C, Keren B, et al. Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies. Nat Genet. 2015;47:1131–40.",
      "volume": "47",
      "year": "2015"
    },
    {
      "DOI": "10.1182/blood-2015-09-668673",
      "author": "AS Harutyunyan",
      "doi-asserted-by": "publisher",
      "first-page": "362",
      "journal-title": "Blood",
      "key": "102_CR25",
      "unstructured": "Harutyunyan AS, Giambruno R, Krendl C, Stukalov A, Klampfl T, Berg T, et al. Germline RBBP6 mutations in familial myeloproliferative neoplasms. Blood. 2016;127:362–5.",
      "volume": "127",
      "year": "2016"
    },
    {
      "DOI": "10.1101/gr.107524.110",
      "author": "A Mckenna",
      "doi-asserted-by": "publisher",
      "first-page": "1297",
      "journal-title": "Genome Res",
      "key": "102_CR26",
      "unstructured": "Mckenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.",
      "volume": "20",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nature19057",
      "author": "M Lek",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Nature",
      "key": "102_CR27",
      "unstructured": "Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–91.",
      "volume": "536",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nmeth0410-248",
      "author": "IA Adzhubei",
      "doi-asserted-by": "publisher",
      "first-page": "248",
      "journal-title": "Nat Methods",
      "key": "102_CR28",
      "unstructured": "Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nprot.2009.86",
      "author": "P Kumar",
      "doi-asserted-by": "publisher",
      "first-page": "1073",
      "journal-title": "Nat Protoc",
      "key": "102_CR29",
      "unstructured": "Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81.",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1182/blood-2011-05-356204",
      "author": "M Li",
      "doi-asserted-by": "publisher",
      "first-page": "5914",
      "journal-title": "Blood",
      "key": "102_CR30",
      "unstructured": "Li M, Collins R, Jiao Y, Ouillette P, Bixby D, Erba H, et al. Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia. Blood. 2011;118:5914–7.",
      "volume": "118",
      "year": "2011"
    },
    {
      "DOI": "10.3324/haematol.2011.057901",
      "author": "E Tiacci",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Haematologica",
      "key": "102_CR31",
      "unstructured": "Tiacci E, Grossmann V, Martelli MP, Kohlmann A, Haferlach T, Falini B. The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia. Haematologica. 2012;97:3–5.",
      "volume": "97",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s00277-013-1827-9",
      "author": "G Rotunno",
      "doi-asserted-by": "publisher",
      "first-page": "523",
      "journal-title": "Ann Hematol",
      "key": "102_CR32",
      "unstructured": "Rotunno G, Guglielmelli P, Biamonte F, Rumi E, Cazzola M, Vannucchi AM. Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms. Ann Hematol. 2014;93:523–4.",
      "volume": "93",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.molimm.2006.02.029",
      "author": "W Al-Kandari",
      "doi-asserted-by": "publisher",
      "first-page": "311",
      "journal-title": "Mol Immunol",
      "key": "102_CR33",
      "unstructured": "Al-Kandari W, Jambunathan S, Navalgund V, Koneni R, Freer M, Parimi N, et al. ZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcription. Mol Immunol. 2007;44:311–21.",
      "volume": "44",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.jmb.2007.04.033",
      "author": "W Al-Kandari",
      "doi-asserted-by": "publisher",
      "first-page": "1175",
      "journal-title": "J Mol Biol",
      "key": "102_CR34",
      "unstructured": "Al-Kandari W, Koneni R, Navalgund V, Aleksandrova A, Jambunathan S, Fontes JD. The zinc finger proteins ZXDA and ZXDC form a complex that binds CIITA and regulates MHC II gene transcription. J Mol Biol. 2007;369:1175–87.",
      "volume": "369",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.molimm.2013.07.001",
      "author": "JE Ramsey",
      "doi-asserted-by": "publisher",
      "first-page": "768",
      "journal-title": "Mol Immunol",
      "key": "102_CR35",
      "unstructured": "Ramsey JE, Fontes JD. The zinc finger transcription factor ZXDC activates CCL2 gene expression by opposing BCL6-mediated repression. Mol Immunol. 2013;56:768–80.",
      "volume": "56",
      "year": "2013"
    },
    {
      "DOI": "10.1621/nrs.06009",
      "author": "L Wang",
      "doi-asserted-by": "crossref",
      "first-page": "e009",
      "journal-title": "Nucl Recept Signal",
      "key": "102_CR36",
      "unstructured": "Wang L, Tsai CC. Atrophin proteins: an overview of a new class of nuclear receptor corepressors. Nucl Recept Signal. 2008;6:e009.",
      "volume": "6",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ng0595-99",
      "author": "I Yazawa",
      "doi-asserted-by": "publisher",
      "first-page": "99",
      "journal-title": "Nat Genet",
      "key": "102_CR37",
      "unstructured": "Yazawa I, Nukina N, Hashida H, Goto J, Yamada M, Kanazawa I. Abnormal gene product identified in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) brain. Nat Genet. 1995;10:99–103.",
      "volume": "10",
      "year": "1995"
    },
    {
      "DOI": "10.1083/jcb.150.5.939",
      "author": "JD Wood",
      "doi-asserted-by": "publisher",
      "first-page": "939",
      "journal-title": "J Cell Biol",
      "key": "102_CR38",
      "unstructured": "Wood JD, Nucifora Jr FC, Duan K, Zhang C, Wang J, Kim Y, et al. Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription. J Cell Biol. 2000;150:939–48.",
      "volume": "150",
      "year": "2000"
    },
    {
      "DOI": "10.1182/blood.V84.5.1650.1650",
      "author": "A Butturini",
      "doi-asserted-by": "crossref",
      "first-page": "1650",
      "journal-title": "Blood",
      "key": "102_CR39",
      "unstructured": "Butturini A, Gale RP, Verlander PC, Adler-Brecher B, Gillio AP, Auerbach AD. Hematologic abnormalities in Fanconi anemia: an International Fanconi Anemia Registry study. Blood. 1994;84:1650–5.",
      "volume": "84",
      "year": "1994"
    },
    {
      "DOI": "10.1038/sj.ejhg.5200248",
      "author": "M Wijker",
      "doi-asserted-by": "publisher",
      "first-page": "52",
      "journal-title": "Eur J Hum Genet",
      "key": "102_CR40",
      "unstructured": "Wijker M, Morgan NV, Herterich S, Van Berkel CG, Tipping AJ, Gross HJ, et al. Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet. 1999;7:52–9.",
      "volume": "7",
      "year": "1999"
    }
  ],
  "reference-count": 40,
  "references-count": 40,
  "resource": {
    "primary": {
      "URL": "http://humgenomics.biomedcentral.com/articles/10.1186/s40246-017-0102-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Whole-exome sequencing identifies novel candidate predisposition genes for familial polycythemia vera"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "11"
}